Overview

  • Product nameNebivolol hydrochloride
  • Description
    Selective β1 antagonist
  • Biological descriptionSelective β1 adrenergic antagonist. Vasodilation mediated by endothelium-dependent mechanisms.
  • Purity> 99%

Properties

    References for Nebivolol hydrochloride (ab120790)

    This product has been referenced in:
    • Sorrentino SA  et al. Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional ß1-blockade. J Am Coll Cardiol 57:601-11 (2011). Read more (PubMed: 21272752) »
    • Sacco G  et al. Combined antihypertensive and cardioprotective effects of nebivolol and hydrochlorothiazide in spontaneous hypertensive rats. Future Cardiol 7:757-63 (2011). Read more (PubMed: 22050062) »
    • Gupta S & Wright HM Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide. Cardiovasc Ther 26:189-202 (2008). Read more (PubMed: 18786089) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120790.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"